Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Garama

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Experimental & Clinical Cancer Research : CR|April 25, 2023
MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostatJasmine Chen, Aleks C Guanizo, W Samantha N Jakasekara, et al.
Science (New York, N.Y.)|February 19, 2021
Structure and dynamics of the CGRP receptor in apo and peptide-bound formsTracy M Josephs, Matthew J Belousoff, Yi-Lynn Liang, et al.
Nature Communications|August 1, 2020
STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1β expressionJesse J Balic, Hassan Albargy, Kevin Luu, et al.
Molecular Cell|December 15, 2021
MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinaseDhanya Sooraj, Claire Sun, Anh Doan, et al.
Oncogene|January 26, 2018
The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53Anette Szczepny, Kirstyn Carey, Lisa McKenzie, et al.
Nature Immunology|November 21, 2024
A STAT3-STING-IFN axis controls the metastatic spread of small cell lung cancerAleks C Guanizo, Quinton Luong, W Samantha N Jayasekara, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Experimental & Clinical Cancer Research : CR|April 25, 2023
MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostatJasmine Chen, Aleks C Guanizo, W Samantha N Jakasekara, et al.
Science (New York, N.Y.)|February 19, 2021
Structure and dynamics of the CGRP receptor in apo and peptide-bound formsTracy M Josephs, Matthew J Belousoff, Yi-Lynn Liang, et al.
Nature Communications|August 1, 2020
STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1β expressionJesse J Balic, Hassan Albargy, Kevin Luu, et al.
Molecular Cell|December 15, 2021
MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinaseDhanya Sooraj, Claire Sun, Anh Doan, et al.
Oncogene|January 26, 2018
The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53Anette Szczepny, Kirstyn Carey, Lisa McKenzie, et al.
Nature Immunology|November 21, 2024
A STAT3-STING-IFN axis controls the metastatic spread of small cell lung cancerAleks C Guanizo, Quinton Luong, W Samantha N Jayasekara, et al.
Pageof 2